Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
0.8611 USD   -2.15%
09/27European ADRs Climb Higher in Tuesday Trading
MT
09/26Mereo BioPharma Says Rubric Capital Management Rejected Offer to Resolve Proxy Contest
MT
09/26Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putting Rubric Principal and Second New Director on the Board
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on MEREO BIOPHARMA GROUP PLC
Target Price consensus revisions : last 18 months
Recommendations (Chart) MEREO BIOPHARMA GROUP PLC
Analyst Recommendations on MEREO BIOPHARMA GROUP PLC
08/12Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target
MT
06/06Needham Adjusts Price Target on Mereo BioPharma Group to $5 From $10, Reiterates Buy Ratin..
MT
2021Mereo BioPharma : BTIG Initiates Mereo BioPharma at Buy Rating With $10 Price Target
MT
2021Mereo BioPharma : Needham Starts Mereo BioPharma Group at Buy With $10 Price Target
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 77,28 GBX
Average target price 523,80 GBX
Spread / Average Target 578%
High Price Target 683,60 GBX
Spread / Highest target 785%
Low Price Target 345,80 GBX
Spread / Lowest Target 347%
Consensus detail
Consensus revision (last 18 months)